Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Itasca › NPI 1083698534
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $3.37M by Medicaid between Jan 2018 and Dec 2024, across 127 billing codes. Its largest line is 86480, — 28% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
ITASCA, IL 60143
33aNPI1083698534assigned 11/29/2005
33bProvider typeClinical Medical Laboratory
28Total paid$3.37M
24GClaims518,533
24DCodes billed127
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#48 of 235
Median peer was paid$123K
This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826,373$378K
201935,361$827K
202018,237$215K
202114,710$136K
202220,172$221K
2023156,566$621K
2024incomplete247,114$975K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
86480 28% 19,947 18,494 $945K
82507 8.2% 23,251 18,149 $276K
82140 4.4% 23,224 18,169 $150K
83945 4.1% 23,204 18,153 $138K
80053 Comprehensive metabolic panel 2.6% 10,905 9,762 $86K
87086 Culture, bacterial; quantitative colony count, urine 2.4% 11,039 9,729 $82K
83735 2.2% 23,749 18,544 $73K
84443 Thyroid stimulating hormone (TSH) 1.9% 5,256 4,704 $66K
82340 1.9% 23,454 18,336 $64K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.9% 672 668 $64K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.9% 1,927 1,707 $63K
82570 1.9% 25,538 20,255 $62K
115 more codes
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.8% 705 $62K
84105 1.7% 23,448 $57K
82436 1.7% 23,210 $56K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 11,115 $55K
84300 1.6% 23,443 $53K
84392 1.6% 22,980 $53K
84540 1.6% 23,292 $53K
82615 1.6% 13,705 $52K
84560 1.5% 23,196 $51K
84133 1.4% 23,203 $48K
80061 Lipid panel 1.4% 7,994 $47K
84702 1.4% 5,718 $46K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.2% 3,255 $42K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 1,383 $36K
83986 1.1% 23,055 $36K
82247 <1% 8,672 $34K
81050 <1% 23,150 $32K
86003 <1% 573 $32K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 536 $32K
83655 <1% 3,054 $31K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,750 $29K
82365 <1% 5,720 $29K
83036 Hemoglobin; glycosylated (A1C) <1% 4,894 $26K
87088 <1% 3,028 $24K
87186 <1% 2,720 $23K
82248 <1% 7,151 $15K
80050 General health panel <1% 479 $14K
86696 <1% 751 $13K
81001 <1% 5,409 $12K
84439 <1% 1,719 $12K
86695 <1% 895 $11K
82607 <1% 974 $10K
82652 <1% 464 $10K
80048 Basic metabolic panel (calcium, ionized) <1% 1,780 $8K
87081 <1% 1,709 $8K
83525 <1% 930 $8K
82746 <1% 703 $7K
86706 <1% 518 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 669 $7K
87905 <1% 771 $7K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 277 $6K
86038 <1% 549 $6K
80305 <1% 694 $5K
82670 <1% 356 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 133 $5K
87338 <1% 388 $5K
82043 <1% 1,407 $4K
86694 <1% 404 $4K
87102 <1% 787 $4K
85027 <1% 916 $4K
86735 <1% 320 $3K
86787 <1% 279 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 98 $3K
86765 <1% 329 $3K
82728 <1% 477 $3K
82785 <1% 389 $3K
83540 <1% 650 $3K
85610 <1% 1,034 $3K
86769 <1% 71 $3K
86677 <1% 242 $3K
87625 <1% 101 $3K
83550 <1% 375 $2K
87340 <1% 180 $2K
81003 <1% 1,106 $2K
87077 <1% 279 $2K
36415 Collection of venous blood by venipuncture <1% 914 $1K
84144 <1% 141 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 42 $1K
87070 <1% 237 $1K
83090 <1% 110 $1K
83970 <1% 40 $1K
88304 <1% 26 $1K
85018 <1% 626 $1K
84156 <1% 493 $1K
84153 <1% 78 $967.96
86235 <1% 85 $944.29
86592 <1% 281 $941.94
87480 <1% 49 $847.42
87510 <1% 49 $847.42
82131 <1% 83 $774.38
86376 <1% 88 $694.58
85014 <1% 408 $682.73
86762 <1% 80 $658.34
82274 <1% 59 $657.69
84100 <1% 221 $648.18
84432 <1% 45 $592.90
87660 <1% 49 $543.53
85379 <1% 75 $458.81
83880 <1% 26 $423.46
83001 <1% 33 $410.59
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 15 $410.24
87109 <1% 38 $354.42
85652 <1% 163 $350.41
84550 <1% 142 $305.86
82947 <1% 121 $287.57
84460 <1% 135 $240.65
83002 <1% 34 $216.04
83690 <1% 42 $208.95
82105 <1% 14 $202.95
84450 <1% 124 $201.20
82565 <1% 88 $182.16
80076 <1% 27 $180.72
84146 <1% 19 $179.41
86800 <1% 16 $166.32
82465 <1% 29 $115.04
82310 <1% 60 $114.06
80051 <1% 45 $109.92
85045 <1% 38 $87.73
86593 <1% 24 $79.55
86431 <1% 13 $71.55
86850 <1% 12 $63.37
82150 <1% 12 $54.34
85048 <1% 22 $38.38
36416 <1% 50 $3.03
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 0% 184 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.